Related News for Debra Auguste
ChE Professor Debra Auguste was selected as an American Institute for Medical and Biological Engineering (AIMBE) Fellow in recognition of “her distinguished and continuing achievements in medical and biological engineering”.
ChE Professor Debra Auguste was awarded a patent for “Cationic polymers as co-drugs for chemotherapeutic agents”. Abstract Source: USPTO A method for treating a biological cell is disclosed. The method administers a mixture of a chemotherapeutic drug and a co-drug that facilitates delivery of the chemotherapeutic drug to the nucleus of the cell. Examples of […]
ChE Professor Debra Auguste is collaborating with Boston Children’s Hospital to develop new treatments to target and treat patients with triple-negative breast cancer.
ChE Professor Debra Auguste’s article on “Targeted Lipid Nanoemulsions Encapsulating Epigenetic Drugs Exhibit Selective Cytotoxicity on CDH1/FOXM1+ Triple Negative Breast Cancer Cells” published in Molecular Pharmaceutics.
Chemical Engineering Professor Debra Auguste’s research paper, Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis, was recently published in Sciences Advances journal.
MBF Bioscience recently selected ChE PhD student Danielle Large as a NeuroArt winner and her work was featured on the cover image of the November 2018 issue of the Journal of Neuroscience Research.
ChE Professor Debra Auguste was featured in the latest Virtual Issue of Bioconjugate Chemistry from ACS (American Chemical Society). The article is titled “Women in Bioconjugate Chemistry: Celebrating Women Scientists”. Read it here: Women in Bioconjugate Chemistry Virtual Issue. “Celebrate the women who are collaborating across disciplines, developing new understanding and new ideas. Celebrate the women […]
ChE Professor Debra Auguste was selected as a member of the Board of Directors for the Biomedical Engineering Society (BMES), the lead society and professional home for biomedical engineering and bioengineering.
ChE Professor Debra Auguste has been selected as a fellow of the Biomedical Engineering Society (BMES) for her exceptional achievements and significant contributions within the biomedical engineering field.
ChE Professor Debra Auguste is researching a different way to approach cancer treatment without taking an extreme toll on patients.
New ChE Professor Debra Auguste is studying human biology to develop better medical therapies and drug delivery methods.